Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cardiotoxicity × schizandrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cardiotoxicity 1

Interventions

Doxorubicin 13 Exercise 7 Dexrazoxane 7 Cyclophosphamide 7 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Echocardiography 3 Docetaxel 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Trastuzumab 2 Tablets 2 Prednisone 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Cisplatin 2 Chemotherapy, Adjuvant 2 Bleomycin 2 Bisoprolol 2 sulforaphane 1 schizandrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06214195 2024-01-19

START

Zhejiang Cancer Hospital

Phase 3 Recruiting

Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡